Dr. Anders, a native of Burlington, N.C., an assistant professor in the University of North Carolina at Chapel Hill School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center, was chosen for her work on the identification of the prognosis and treatment of breast
cancer brain metastases.
They and additional co-authors at the MGH Cancer Center, the University of North Carolina, Vanderbilt University and Novartis, identified HER3 — part of the same signaling pathway that includes HER2 — as a possible contributor to anti-HER2 / PI3K resistance in breast
cancer brain metastases.
Not exact matches
It offers cardio protection, it helps lower bad cholesterol, it may help prevent the progression of multiple sclerosis, it has the ability to regenerate
brain cells after a stroke, it has the ability to cross the blood -
brain barrier to potentially ward off Alzheimer's disease, apparently it's good at wiping amyloid plaque from the
brain (which studies haves linked to Alzheimer's), it may help to prevent certain types of
cancer, and studies have shown that it inhibits
cancer cell growth and
metastases (meaning it keeps
cancer from spreading).
Dr Priscilla Brastianos, MD, a neuro - oncologist and Director of the
Brain Metastasis Program at Massachusetts General Hospital, Boston, USA, will say: «
Brain metastases are a devastating complication of
cancer.
«
Brain metastases represent an unmet need in current
cancer care.
Approximately eight to ten percent of
cancer patients will develop
brain metastases, and treatment options are limited.
Many lung
cancer trials have traditionally excluded patients with
brain metastases at baseline, expecting that the presence of
metastases would create negative results that could in turn create the appearance of drug failure.
Research from McMaster University has identified new regulators of
brain metastases in patients with lung
cancer.
Brain metastases are the most common brain tumour in adults and are a leading cause of death in cancer pati
Brain metastases are the most common
brain tumour in adults and are a leading cause of death in cancer pati
brain tumour in adults and are a leading cause of death in
cancer patients.
«If you look at a set of lung
cancer patients, like we did in the paper, who develop brain metastases, they all have those two genes in their primary lung cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
cancer patients, like we did in the paper, who develop
brain metastases, they all have those two genes in their primary lung
cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and
Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hospital.
«
Brain metastases are a secondary brain tumour, which means they are caused by cancer cells that escape from primary tumours like lung, breast or melanoma, and travel to the brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMa
Brain metastases are a secondary
brain tumour, which means they are caused by cancer cells that escape from primary tumours like lung, breast or melanoma, and travel to the brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMa
brain tumour, which means they are caused by
cancer cells that escape from primary tumours like lung, breast or melanoma, and travel to the
brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMa
brain,» said Mohini Singh, the study's primary author and a PhD candidate in biochemistry at the Michael G. DeGroote School of Medicine at McMaster.
The study used samples from lung
cancer patients with
brain metastases.
«Rare mutation may extend survival in lung
cancer patients with
brain metastases.»
Approximately 30 percent of patients with
cancer develop
brain metastases, and the incidence of these lesions is rising.
Patients were stratified by number of
brain metastases (1 vs. 2 - 3), primary
cancer type (melanoma vs. other histology) and pre-operative tumor size (less than vs. greater than three centimeters).
«In
cancer, it's usually the
metastases to the lung, liver or
brain that kill the patient, but it's hard to get tissue safely from these areas,» said Rick Lanman, MD, Guardant Health's chief medical officer.
In the case of breast
cancer driven by overexpression of the HER2 gene, up to 50 percent of patients treated with targeted therapies eventually develop
brain metastases, which are inevitably fatal.
After confirming in mouse models that cells from HER2 - positive breast
cancers became resistant to anti-HER2 treatment when implanted into the
brain but not into other tissues, the investigators found that HER3 is overexpressed in
brain metastases of HER2 - positive breast
cancers from both mice and human patients.
«Metastatic
brain tumors — often from lung, breast or skin
cancers — are the most commonly observed tumors within the
brain and account for about 40 percent of advanced melanoma
metastases.
«Stem - cell - based therapy promising for treatment of breast
cancer metastases in the
brain.»
«Stem cell - based therapy for targeting skin - to -
brain cancer: Stem cells loaded with oncolytic viruses show promising results in preclinical models for targeting skin
cancer metastases in the
brain.»
Tagged therapeutic stem cells (green) are targeting breast
cancer metastases (red) in the
brain of a mouse model.
«Metastatic
brain tumors — often from lung, breast or skin
cancers — are the most commonly observed tumors within the
brain and account for about 30 percent of advanced breast
cancer metastases,» says Khalid Shah, MS, PhD, director of the Molecular Neurotherapy and Imaging Laboratory in the MGH Departments of Radiology and Neurology, who led the study.
Current treatments for both primary
brain tumors and
brain metastases (
cancer that has spread to the
brain from another place in the body) are low in number and short on effectiveness.
A phase 3 trial of whole
brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung
cancer and 1 to 3
brain metastases: Radiation Therapy Oncology Group 0320.
Novel strategies that are effective in treating
brain metastases in patients with lung
cancer are needed.
P - glycoprotein mediated efflux limits substrate and drug uptake in a preclinical
brain metastases of breast
cancer model.
Characterization of passive permeability at the blood — tumor barrier in five preclinical models of
brain metastases of breast
cancer.
Location: NC1 - 202 Title: «
Brain Metastases - Our Advances and Failures» The Department of Cellular and Molecular Medicine welcomes guest speaker Dr. Paul R. Lockman, Professor and Chair Basic Pharmaceutical Sciences, Associate Center Director for Translational Research, West Virginia University
Cancer Institute.
Faculty in the
Brain and Spinal Tumor Program focus on clinical research and treatment of primary brain tumors, neoplastic meningitis, brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
Brain and Spinal Tumor Program focus on clinical research and treatment of primary
brain tumors, neoplastic meningitis, brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
brain tumors, neoplastic meningitis,
brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and
cancer pain management.
A phase III study of TTFields following Stereotactic Radiosurgery for 1 - 10
Brain Metastases from Non-Small-Cell Lung
Cancer more...
Brain metastases are the most common type of brain tumors, and it is estimated that about 1/3 of cancer patients will develop brain metast
Brain metastases are the most common type of
brain tumors, and it is estimated that about 1/3 of cancer patients will develop brain metast
brain tumors, and it is estimated that about 1/3 of
cancer patients will develop
brain metast
brain metastases.
For patients with non-small cell lung
cancer with
brain metastases, treatment with whole
brain radiotherapy may not offer much benefit.